Collaborating with physicians, psychologists, neurologists, chiropractors, attorneys, and other professionals to deliver evidence-based, drug-free neurological intervention.
📝 Submit Patient ReferralAt Marietta Brain Health, we believe the most effective patient outcomes happen when providers work together. We welcome referrals from physicians, psychologists, psychiatrists, neurologists, chiropractors, social workers, attorneys, and other professionals who recognize the value of evidence-based, drug-free neurological intervention.
Neurofeedback is not an alternative to your care — it's a complement to it. For patients who have plateaued in treatment, who cannot tolerate pharmacological side effects, or who are seeking to reduce long-term medication dependence under medical supervision, neurofeedback offers a clinically supported path toward improved neurological self-regulation.
The core mechanism is operant conditioning of brainwave activity. Using real-time EEG feedback, the brain is trained to shift dysregulated activity patterns toward more efficient, stable baselines. Unlike pharmaceutical intervention, which acts on neurotransmitter chemistry, neurofeedback works directly on the underlying electrical activity of the cortex — targeting the neurological root of dysfunction rather than managing its symptoms.
The effects are cumulative and durable. Research consistently shows that gains from neurofeedback persist after training ends in a way that medication-based improvements typically do not.
We utilize hospital-grade qEEG brain mapping equipment and FDA-cleared neurofeedback systems providing quantitative EEG data across all major frequency bands and all 19 standard cortical sites per the 10-20 international electrode placement system.
Our neurofeedback protocols are individually designed based on each patient's qEEG assessment, symptom profile, and treatment history. Protocol selection is guided by peer-reviewed clinical literature and refined based on ongoing patient response.
Our practitioners hold advanced training in neurofeedback with continuing education aligned with BCIA (Biofeedback Certification International Alliance) standards — the recognized gold standard for clinical competency in this field.
Every session is logged with quantitative data. We track changes in brainwave activity across the course of treatment and generate progress reports that can be shared with referring providers on request.
Neurofeedback is one of the most extensively studied non-pharmacological interventions in clinical psychology and neuroscience. Key research findings relevant to referring providers:
The American Academy of Pediatrics designates neurofeedback as a Level 1 — "Best Support" evidence-based intervention for ADHD. The AAPB assigns it a Level 5 "Efficacious and Specific" rating — equivalent to the highest evidence designation in this classification system, matching the evidence level of stimulant medication without the pharmacological risk profile.
Multiple randomized controlled trials demonstrate significant reduction in self-reported anxiety and depressive symptomatology following neurofeedback training, with effects maintained at 6-month follow-up. Alpha asymmetry protocols targeting left frontal hypoactivation have shown particular promise for treatment-resistant depression.
Research published in peer-reviewed journals including the Journal of Neurotherapy and Applied Psychophysiology and Biofeedback documents significant reduction in PTSD symptom severity (PCL-5 scores) following neurofeedback intervention in veteran and civilian populations.
Post-concussive neurofeedback research demonstrates improvements in cognitive processing speed, working memory, and emotional regulation in patients with mild-to-moderate TBI, including cases where symptomatology has persisted well beyond the standard recovery window.
Dr. Barry Sterman's foundational research at UCLA — now replicated across multiple independent laboratories — established that sensorimotor rhythm (SMR) training elevates seizure threshold in patients with intractable epilepsy. This remains one of the earliest and most rigorous neurofeedback evidence bases.
Emerging research supports neurofeedback's role in improving social communication, reducing repetitive behaviors, and enhancing emotional regulation in ASD populations, with effect sizes comparable to behavioral interventions when combined with existing therapeutic frameworks.
All research citations, white papers, and NIH-linked studies are available on our Research page. We are happy to provide condition-specific literature packages to referring providers on request.
Every new referral begins with a comprehensive intake session and quantitative EEG brain mapping. This produces a full-brain activity profile that identifies specific sites and frequencies of dysregulation. The assessment typically takes 60–90 minutes and generates a report we can share with your office.
Based on the qEEG results, clinical presentation, and your referral notes, we design an individualized training protocol. We welcome your clinical input and treatment history — the more context you provide, the more precisely we can target the intervention.
Standard neurofeedback training sessions run 30–45 minutes, typically one to three times per week. Most patients complete 20–40 sessions for a full course of treatment, though clinical response is monitored continuously and protocols are adjusted as needed.
We generate written progress reports at defined intervals and at the completion of a treatment course. Reports include quantitative data, clinical observations, and patient-reported outcome measures — available to referring providers with appropriate patient authorization.
We maintain open lines of communication with referring providers throughout the course of treatment. For complex cases — particularly those involving psychiatric medication management, neurological comorbidities, or legal proceedings — we welcome case consultation calls.
Patients who tend to benefit most from neurofeedback referral include those who:
We work with attorneys, case managers, and insurance professionals who require objective neurological assessment data in the context of personal injury, disability, workers' compensation, and family court proceedings. Our qEEG assessment produces quantitative, objective data documenting neurological dysfunction — data that can support or corroborate a client's reported cognitive and behavioral symptoms with measurable clinical evidence. We are experienced in producing documentation appropriate for legal proceedings and can discuss expert consultation on a case-by-case basis.
Contact us to discuss a referral, request a literature package, or schedule a case consultation.
Marietta Brain Health
Common questions